Christophe Willekens

12PUBLICATIONS
75CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 26, 2026
Clonal memory of cell division in humans diverges between healthy haematopoiesis and acute myeloid leukaemia.

|Jun 24, 2025
Comparison of induction with arsenic trioxide or chemotherapy in a real-world cohort of patients with high-risk acute promyelocytic leukemia.

Delphine Lebon, Audrey Da Rocha, Bruno Cassinat

|Apr 17, 2025
Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients.

Christophe Willekens, Alexandre Bazinet, Samy Chraibi

|Apr 26, 2023
SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice.

Christophe Willekens, Lucie Laplane, Tracy Dagher

|Oct 14, 2020
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.

Olga Salamero, Pau Montesinos, Christophe Willekens

|Oct 12, 2020
Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study.

C Willekens, R Rahme, M Duchmann

Pageof 2

Frequent Collaborators

3 joint publications

Stephane De Botton

2 joint publications

Delphine Lebon

2 joint publications

Emmanuel Raffoux

2 joint publications

Nicolas Duployez